Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
PLoS Med
    August 2026
  1. KAMTCHUM-TATUENE J, Farrell J, Nolan J, Lessels S, et al
    Time trends in stroke incidence and modifiable risk factor prevalence in England (2018-2024): A record linkage population-based study.
    PLoS Med. 2026;23:e1004999.
    >> Share

    July 2026
  2. GRAIS RF
    Whose fears count? Legitimacy, trust and viral outbreak responses after COVID-19.
    PLoS Med. 2026;23:e1005184.
    >> Share

  3. LI W, Yang W, Liu Y, Yao Y, et al
    Assessing spatial transmission risk of respiratory infectious diseases across cities of different socioeconomic tiers in China: A modelling study.
    PLoS Med. 2026;23:e1005172.
    >> Share

    June 2026
  4. GHISI GLM, Carson RP, Turk Adawi K, Ding R, et al
    Comparisons of core component delivery in cardiac rehabilitation programs by country income classification and decade based on the 2025 Global Audit Update: A survey study.
    PLoS Med. 2026;23:e1005151.
    >> Share

    May 2026
  5. KRUK ME, Kapoor NR, Arsenault C, Carai S, et al
    Health system use and experience among people with poor mental health: A cross-sectional analysis of the People's Voice Survey in 18 countries.
    PLoS Med. 2026;23:e1004745.
    >> Share

  6. O'HAGAN A, Pechey R, Forde H, Bandy L, et al
    Adherence to voluntary UK sugar, salt, and calorie reduction targets in the highest-grossing restaurant chains: A cross-sectional study.
    PLoS Med. 2026;23:e1004681.
    >> Share

  7. GOODFELLOW L, Quilty BJ, van Zandvoort K, Edmunds WJ, et al
    Social contact patterns in the United Kingdom following the COVID-19 pandemic: The Reconnect cross-sectional survey.
    PLoS Med. 2026;23:e1005038.
    >> Share

  8. JANSEN E, Bockstal V, Herschke F, Olsson Gisleskog P, et al
    Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials.
    PLoS Med. 2026;23:e1004609.
    >> Share

    March 2026
  9. KAMPITSI CE, Louro J, Mogensen H, Erdmann F, et al
    Childhood cancer in Sweden during the COVID-19 pandemic: Temporal patterns in incidence and survival in a nationwide register-based cohort study.
    PLoS Med. 2026;23:e1004934.
    >> Share

  10. ABDEL-QADIR H, Bhatt HA, Swayze S, Paterson M, et al
    Association between COVID-19 vaccination and sudden death in apparently healthy younger individuals: A population-based case-control study.
    PLoS Med. 2026;23:e1004924.
    >> Share

  11. XIAO H, Bai G, Liu F, Cui Y, et al
    Policy stringency during the COVID-19 pandemic and healthcare services utilization in China: An interrupted time-series analysis.
    PLoS Med. 2026;23:e1004672.
    >> Share

    January 2026
  12. TATEMATSU D, Nakamura N, Abe MS, Ishikawa T, et al
    Psychological distress among Japanese high school students during the COVID-19 pandemic: An energy landscape analysis.
    PLoS Med. 2026;23:e1004884.
    >> Share

  13. MONOI A, Endo A, Procter SR, Leuba SI, et al
    The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study.
    PLoS Med. 2026;23:e1004625.
    >> Share

    November 2025
  14. HEITKAMP P, Chijioke-Akaniro O, Pai M
    From dependence to self-reliance: The future of the global tuberculosis response.
    PLoS Med. 2025;22:e1004824.
    >> Share

    October 2025
  15. LEWNARD JA, Malden DE, Hong V, Skela J, et al
    Comparative risk of post-acute sequelae among adults following SARS-CoV-2 or influenza virus infection: A retrospective cohort study among United States adults.
    PLoS Med. 2025;22:e1004777.
    >> Share

  16. KAWAMOTO A, Hashida M, Ishida K, Furihata K, et al
    Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine: A phase 3, randomized, active-controlled study.
    PLoS Med. 2025;22:e1004499.
    >> Share

    September 2025
  17. LEWIS BR, Hendrick J, Byrne K, Odette M, et al
    Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.
    PLoS Med. 2025;22:e1004519.
    >> Share

  18. PREISS A, Bhatia A, Aragon LV, Baratta JM, et al
    Effect of Paxlovid treatment during acute COVID-19 on Long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia.
    PLoS Med. 2025;22:e1004711.
    >> Share

    July 2025
  19. KNOWLTON KU, Siegel LK, Barkauskas CE, Bhagani S, et al
    Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials.
    PLoS Med. 2025;22:e1004616.
    >> Share

    June 2025
  20. GOODFELLOW L, Procter SR, Koltai M, Waterlow NR, et al
    The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis.
    PLoS Med. 2025;22:e1004655.
    >> Share

    March 2025
  21. AHMADI-ABHARI S, Bandosz P, Shipley MJ, Lindbohm JV, et al
    Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020-2022.
    PLoS Med. 2025;22:e1004541.
    >> Share

    February 2025
  22. RAZIEH C, Powell B, Drummond R, Ward IL, et al
    Understanding the quality of ethnicity data recorded in health-related administrative data sources compared with Census 2021 in England.
    PLoS Med. 2025;22:e1004507.
    >> Share

    January 2025
  23. BHATIA A, Preiss AJ, Xiao X, Brannock MD, et al
    Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C.
    PLoS Med. 2025;22:e1004493.
    >> Share

  24. PETER RS, Nieters A, Gopel S, Merle U, et al
    Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.
    PLoS Med. 2025;22:e1004511.
    >> Share

  25. ODD D, Stoianova S, Williams T, Fleming P, et al
    Child mortality in England after national lockdowns for COVID-19: An analysis of childhood deaths, 2019-2023.
    PLoS Med. 2025;22:e1004417.
    >> Share

  26. RAGONNET R, Hughes AE, Shipman DS, Meehan MT, et al
    Estimating the impact of school closures on the COVID-19 dynamics in 74 countries: A modelling analysis.
    PLoS Med. 2025;22:e1004512.
    >> Share

    November 2024
  27. HO FK, Dale C, Mizani MA, Bolton T, et al
    Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study.
    PLoS Med. 2024;21:e1004485.
    >> Share

    September 2024
  28. INIZAN C, Courtot A, Sturmach C, Griffon AF, et al
    Levels and functionality of Pacific Islanders' hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.
    PLoS Med. 2024;21:e1004397.
    >> Share

  29. SCHILLING WHK, Mukaka M, Callery JJ, Llewelyn MJ, et al
    Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
    PLoS Med. 2024;21:e1004428.
    >> Share

    July 2024
  30. BONNET G, Bimba J, Chavula C, Chifamba HN, et al
    Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
    PLoS Med. 2024;21:e1004429.
    >> Share

  31. FORMANEK T, Potocar L, Wolfova K, Melicharova H, et al
    Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia.
    PLoS Med. 2024;21:e1004422.
    >> Share

    June 2024
  32. SAMUEL M, Park RY, Eastwood SV, Eto F, et al
    Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform.
    PLoS Med. 2024;21:e1004398.
    >> Share

    May 2024
  33. EUVRARD J, Timmerman V, Keene CM, Phelanyane F, et al
    The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.
    PLoS Med. 2024;21:e1004407.
    >> Share

    April 2024
  34. JUNG SM, Loo SL, Howerton E, Contamin L, et al
    Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub.
    PLoS Med. 2024;21:e1004387.
    >> Share

  35. ELIGULASHVILI A, Gordon M, Lee JS, Lee J, et al
    Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment.
    PLoS Med. 2024;21:e1004263.
    >> Share

    February 2024
  36. NICKEL NC, Phillips-Beck W, Enns JE, Ekuma O, et al
    COVID-19 diagnostic testing and vaccinations among First Nations in Manitoba: A nations-based retrospective cohort study using linked administrative data, 2020-2021.
    PLoS Med. 2024;21:e1004348.
    >> Share

  37. MKOMA GF, Agyemang C, Benfield T, Rostila M, et al
    Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark.
    PLoS Med. 2024;21:e1004280.
    >> Share

    January 2024
  38. GHARPURE R, Chard AN, Cabrera Escobar M, Zhou W, et al
    Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
    PLoS Med. 2024;21:e1004333.
    >> Share

  39. PANAGI L, White SR, Pinto Pereira SM, Nugawela MD, et al
    Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.
    PLoS Med. 2024;21:e1004315.
    >> Share

    December 2023
  40. LEBLANC J, Dusserre-Telmon L, Chauvin A, Simon T, et al
    Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.
    PLoS Med. 2023;20:e1004317.
    >> Share

    November 2023
  41. HOGAN AB, Wu SL, Toor J, Olivera Mesa D, et al
    Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.
    PLoS Med. 2023;20:e1004195.
    >> Share

  42. CARTULIARES MB, Rosenvinge FS, Mogensen CB, Skovsted TA, et al
    Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: A multicentre randomised controlled trial.
    PLoS Med. 2023;20:e1004314.
    >> Share

    September 2023
  43. WATKINSON RE, Williams R, Gillibrand S, Munford L, et al
    Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England.
    PLoS Med. 2023;20:e1004289.
    >> Share

  44. KUCHARSKI AJ, Chung K, Aubry M, Teiti I, et al
    Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.
    PLoS Med. 2023;20:e1004283.
    >> Share

    July 2023
  45. XIONG X, Lui DTW, Chung MSH, Au ICH, et al
    Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    PLoS Med. 2023;20:e1004274.
    >> Share

  46. HILLARY RF, McCartney DL, Smith HM, Bernabeu E, et al
    Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.
    PLoS Med. 2023;20:e1004247.
    >> Share

  47. ANTILLON M, Li X, Willem L, Bilcke J, et al
    The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach.
    PLoS Med. 2023;20:e1004250.
    >> Share

    June 2023
  48. STOWE J, Miller E, Andrews N, Whitaker HJ, et al
    Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    PLoS Med. 2023;20:e1004245.
    >> Share

  49. SMITH DRM, Shirreff G, Temime L, Opatowski L, et al
    Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
    PLoS Med. 2023;20:e1004240.
    >> Share

  50. QIN K, Honjo K, Sherrill-Mix S, Liu W, et al
    Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
    PLoS Med. 2023;20:e1004157.
    >> Share

  51. MARINCOWITZ C, Bouamra O, Coats T, Surendra Kumar D, et al
    Major trauma presentations and patient outcomes in English hospitals during the COVID-19 pandemic: An observational cohort study.
    PLoS Med. 2023;20:e1004243.
    >> Share

    May 2023
  52. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
    Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
    PLoS Med. 2023;20:e1004237.
    >> Share

  53. BANHOLZER N, Zurcher K, Jent P, Bittel P, et al
    SARS-CoV-2 transmission with and without mask wearing or air cleaners in schools in Switzerland: A modeling study of epidemiological, environmental, and molecular data.
    PLoS Med. 2023;20:e1004226.
    >> Share

    April 2023
  54. MORENO-AGOSTINO D, Fisher HL, Goodman A, Hatch SL, et al
    Long-term psychological distress trajectories and the COVID-19 pandemic in three British birth cohorts: A multi-cohort study.
    PLoS Med. 2023;20:e1004145.
    >> Share

  55. SAXENA S, Chwa C
    Mental disorders and COVID-19 deaths: Clinical, public health, and human rights implications.
    PLoS Med. 2023;20:e1004220.
    >> Share

  56. VIOLATO M, Pollard J, Lloyd A, Roope LSJ, et al
    The COVID-19 pandemic and health-related quality of life across 13 high- and low-middle-income countries: A cross-sectional analysis.
    PLoS Med. 2023;20:e1004146.
    >> Share

  57. TOMLINSON M, Marlow M
    COVID-19 and mental health: Building back better or reimagining a new way forward?
    PLoS Med. 2023;20:e1004216.
    >> Share

  58. AKSUNGER N, Vernot C, Littman R, Voors M, et al
    COVID-19 and mental health in 8 low- and middle-income countries: A prospective cohort study.
    PLoS Med. 2023;20:e1004081.
    >> Share

  59. PINTO DA COSTA M, Stewart R
    Investigating time-dependent COVID-19 pandemic mental health data: Challenges and opportunities of using panel data analysis.
    PLoS Med. 2023;20:e1004219.
    >> Share

  60. MYRAN DT, Roberts R, McArthur E, Jeyakumar N, et al
    Mental health and addiction health service use by physicians compared to non-physicians before and during the COVID-19 pandemic: A population-based cohort study in Ontario, Canada.
    PLoS Med. 2023;20:e1004187.
    >> Share

  61. BU F, Steptoe A, Fancourt D
    Depressive and anxiety symptoms in adults during the COVID-19 pandemic in England: A panel data analysis over 2 years.
    PLoS Med. 2023;20:e1004144.
    >> Share

  62. WITTEVEEN AB, Young SY, Cuijpers P, Ayuso-Mateos JL, et al
    COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence.
    PLoS Med. 2023;20:e1004206.
    >> Share

  63. BEACH B, Steptoe A, Zaninotto P
    Depression and anxiety in people with cognitive impairment and dementia during the COVID-19 pandemic: Analysis of the English Longitudinal Study of Ageing.
    PLoS Med. 2023;20:e1004162.
    >> Share

  64. PATEL V, Fancourt D, Furukawa TA, Kola L, et al
    Reimagining the journey to recovery: The COVID-19 pandemic and global mental health.
    PLoS Med. 2023;20:e1004224.
    >> Share

  65. WELS J, Wielgoszewska B, Moltrecht B, Booth C, et al
    Home working and social and mental wellbeing at different stages of the COVID-19 pandemic in the UK: Evidence from 7 longitudinal population surveys.
    PLoS Med. 2023;20:e1004214.
    >> Share

  66. FUNG KW, Baye F, Baik SH, Zheng Z, et al
    Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US.
    PLoS Med. 2023;20:e1004194.
    >> Share

  67. ROCKERS PC, Leppanen JM, Tarullo A, Coetzee L, et al
    Evaluation of a community health worker home visit intervention to improve child development in South Africa: A cluster-randomized controlled trial.
    PLoS Med. 2023;20:e1004222.
    >> Share

    February 2023
  68. NORDSTROM P, Ballin M, Nordstrom A
    Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden.
    PLoS Med. 2023;20:e1004127.
    >> Share

  69. DAVISSE-PATURET C, Orri M, Legleye S, Florence AM, et al
    Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study.
    PLoS Med. 2023;20:e1004171.
    >> Share

  70. GYLLENBERG D, Bastola K, Wan Mohd Yunus WMA, Mishina K, et al
    Comparison of new psychiatric diagnoses among Finnish children and adolescents before and during the COVID-19 pandemic: A nationwide register-based study.
    PLoS Med. 2023;20:e1004072.
    >> Share

  71. SCHWARZINGER M, Luchini S, Teschl M, Alla F, et al
    Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study.
    PLoS Med. 2023;20:e1004134.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016